Aethlon Medical Return on Tangible Equity 2010-2024 | AEMD

Current and historical return on tangible equity values for Aethlon Medical (AEMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Aethlon Medical Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.01B $0.01B -151.72%
2024-06-30 $-0.01B $0.01B -133.33%
2024-03-31 $-0.01B $0.01B -118.92%
2023-12-31 $-0.01B $0.01B -95.65%
2023-09-30 $-0.01B $0.01B -80.00%
2023-06-30 $-0.01B $0.01B -73.85%
2023-03-31 $-0.01B $0.02B -71.64%
2022-12-31 $-0.01B $0.02B -81.16%
2022-09-30 $-0.01B $0.02B -76.71%
2022-06-30 $-0.01B $0.02B -63.16%
2022-03-31 $-0.01B $0.02B -51.16%
2021-12-31 $-0.01B $0.02B -46.15%
2021-09-30 $-0.01B $0.02B -47.06%
2021-06-30 $-0.01B $0.03B -54.24%
2021-03-31 $-0.01B $0.01B -57.14%
2020-12-31 $-0.01B $0.01B -57.14%
2020-09-30 $-0.01B $0.01B -57.14%
2020-06-30 $-0.01B $0.02B -85.71%
2020-03-31 $-0.01B $0.01B -200.00%
2019-12-31 $-0.01B $0.00B -400.00%
2019-09-30 $-0.01B $0.00B -533.33%
2019-06-30 $-0.01B $0.00B -280.00%
2019-03-31 $-0.01B $0.00B -171.43%
2018-12-31 $-0.01B $0.00B -111.11%
2018-09-30 $-0.00B $0.00B -80.00%
2018-06-30 $-0.00B $0.01B -100.00%
2018-03-31 $-0.01B $0.01B -200.00%
2017-12-31 $-0.01B $0.01B -480.00%
2017-09-30 $-0.01B $0.00B inf%
2017-06-30 $-0.01B $-0.00B inf%
2017-03-31 $-0.01B $0.00B -2800.00%
2016-12-31 $-0.01B $0.00B -2400.00%
2016-09-30 $-0.01B $0.00B -600.00%
2016-06-30 $-0.01B $0.00B -250.00%
2016-03-31 $-0.00B $0.00B -123.08%
2015-12-31 $-0.00B $0.00B -123.08%
2015-09-30 $-0.01B $0.00B -181.82%
2015-06-30 $-0.01B $0.01B -500.00%
2015-03-31 $-0.01B $0.00B 640.00%
2014-12-31 $-0.01B $0.00B 266.67%
2014-09-30 $-0.01B $-0.00B 169.70%
2014-06-30 $-0.02B $-0.00B 152.38%
2014-03-31 $-0.01B $-0.02B 102.13%
2013-12-31 $-0.01B $-0.01B 78.05%
2013-09-30 $-0.01B $-0.01B 64.86%
2013-06-30 $-0.00B $-0.01B 47.06%
2013-03-31 $-0.01B $-0.01B 58.82%
2012-12-31 $-0.01B $-0.01B 70.59%
2012-09-30 $-0.01B $-0.01B 84.85%
2012-06-30 $-0.01B $-0.01B 80.00%
2012-03-31 $-0.01B $-0.01B 114.29%
2011-12-31 $-0.00B $-0.01B 32.00%
2011-09-30 $-0.00B $-0.01B 42.86%
2011-06-30 $-0.01B $-0.01B 80.00%
2011-03-31 $-0.01B $-0.01B 80.00%
2010-12-31 $-0.01B $-0.01B 124.14%
2010-09-30 $-0.01B $-0.01B 133.33%
2010-06-30 $-0.01B $-0.01B 120.00%
2010-03-31 $-0.00B $-0.01B 94.12%
2009-12-31 $-0.00B $-0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.006B $0.001B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $543.768B 21.87
Cigna Group (CI) United States $91.359B 11.95
Humana (HUM) United States $35.896B 16.34
Centene (CNC) United States $30.479B 8.94
Molina Healthcare (MOH) United States $16.633B 13.23
Select Medical Holdings (SEM) United States $5.136B 17.79
Joint (JYNT) United States $0.176B 106.82